VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $138,276 | -31.8% | 12,491 | -0.1% | 0.00% | -100.0% |
Q2 2023 | $202,707 | +419.8% | 12,505 | -2.5% | 0.00% | – |
Q1 2022 | $39,000 | -43.5% | 12,825 | -14.2% | 0.00% | – |
Q4 2021 | $69,000 | -34.9% | 14,947 | -15.8% | 0.00% | – |
Q2 2021 | $106,000 | -4.5% | 17,747 | +1.3% | 0.00% | – |
Q1 2021 | $111,000 | +35.4% | 17,524 | +20.6% | 0.00% | – |
Q4 2020 | $82,000 | – | 14,526 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |